Talking Points
Lepodisiran Phase I Trial
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:05:22
- Mas informaciones
Informações:
Sinopsis
Steven Nissen and C. Michael Gibson discuss the efficacy and safety of lepodisiran, an extended duration short-interfering RNA meant to reduce lipoprotein (a).
